Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine

• Published in: Small (Weinheim an der Bergstrasse, Germany) Vol. 20; no. 25; pp. e2310342 - n/a
• Main Authors: Su, Yanhong, Liu, Bing, Wang, Binghan, Chan, Leung, Xiong, Chan, Lu, Ligong, Zhang, Xuanjun, Zhan, Meixiao, He, Weiling
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.06.2024
• Subjects: Apoptosis; Bimetals; Cancer; Cancer therapies; cancer therapy; Cell death; Coordination compounds; Ferroptosis; Iron; Lipids; metal complexes; Nanoparticles; Peroxides; synergistic therapy; Therapy; Tumors; metal complexes; cancer therapy; ferroptosis; nanoparticles; synergistic therapy
• ISSN: 1613-6810; 1613-6829; 1613-6829
• DOI: 10.1002/smll.202310342

Ferroptosis is a new form of regulated cell death featuring iron‐dependent lipid peroxides accumulation to kill tumor cells. A growing body of evidence has shown the potential of ferroptosis‐based cancer therapy in eradicating refractory malignancies that are resistant to apoptosis‐based conventional therapies. In recent years, studies have reported a number of ferroptosis inducers that can increase the vulnerability of tumor cells to ferroptosis by regulating ferroptosis‐related signaling pathways. Encouraged by the rapid development of ferroptosis‐driven cancer therapies, interdisciplinary fields that combine ferroptosis, pharmaceutical chemistry, and nanotechnology are focused. First, the prerequisites and metabolic pathways for ferroptosis are briefly introduced. Then, in detail emerging ferroptosis inducers designed to boost ferroptosis‐induced tumor therapy, including metal complexes, metal‐based nanoparticles, and metal‐free nanoparticles are summarized. Subsequently, the application of synergistic strategies that combine ferroptosis with apoptosis and other regulated cell death for cancer therapy, with emphasis on the use of both cuproptosis and ferroptosis to induce redox dysregulation in tumor and intracellular bimetallic copper/iron metabolism disorders during tumor treatment is discussed. Finally, challenges associated with clinical translation and potential future directions for potentiating cancer ferroptosis therapies are highlighted. This review summarizes the molecular mechanisms of ferroptosis regulation, systematically outlines various metal complexes and nanoparticles for tumor ferroptosis, and offers insights into precise cancer therapy. Additionally, it discusses the synergistic therapeutic strategies combining ferroptosis with other cell death mechanisms, with emphasis on the potential and prospects of cuproptosis and ferroptosis for tumor treatment.